Anti-infection
-
BA1999 FiacitabineSummary: Fiacitabine (NSC382097; FIAC; FOAC) is a selective HSVDNA replication inhibitor. - BA2000 HN0037Summary: HN0037 is a selective, orally active deconjugulase-initiator inhibitor.
- BA2001 IsookaninSummary: Isookanin is used in studies for a variety of conditions, including tumors, rashes, snake and insect bites, diabetes, and diarrhea.
- BA2004 BaloxavirSummary: Baloxavir (Baloxaviracid), derived from the precursor Baloxavirmarboxil, is a first-of-its-kind, potent and selective cap-dependent nucleic acid endonuclease inhibitor within the PA subunit of influenza A and B virus polymerase.
- BA2005 PimodivirSummary: Pimodivir (VX-787) is an orally available inhibitor.
- BA2007 KIN1148Summary: KIN1148 is a small molecule agonist.
- BA2008 ThymalfasinSummary: Thymalfasin (thymosin-alpha1) is an immunomodulatory compound.
- BA2010 LaninamivirSummary: Laninamivir (R125489) is a potent inhibitor of influenza neuraminidase (NA).
- BA2014 Oseltamivir-acetateSummary: Oseltamivir-acetate is an impurity of Oseltamivir.
- BA2015 OnradivirSummary: An effective anti-influenza virus agent.